ELORAC
Elorac, Inc. is a privately owned, specialty pharmaceutical company engaged in the development and commercialization of novel products for dermatology, allergy and oncology. The Company markets dermatological products in the United States through its dedicated internal sales force. In addition to the newly acquired Heprotect compounds, Elorac’s development pipeline includes: naloxone lotion for treatment of pruritus accompanying cutaneous T-cell lymphoma, a product with orphan drug and fast-track designations from the U.S. Food and Drug Administration; cidoxepin, a highly potent histamine H1-receptor antagonist being developed for relief of chronic urticaria; and a once-weekly tablet for nodulocystic acne.
ELORAC
Social Links:
Industry:
Biopharma Pharmaceutical
Founded:
2009-01-01
Address:
Vernon Hills, Illinois, United States
Country:
United States
Website Url:
http://www.eloracpharma.com
Total Employee:
11+
Status:
Active
Contact:
(847)362-8200
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Dyax
Dyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-04-15 | Gideon Pharmaceuticals | Gideon Pharmaceuticals acquired by Elorac | N/A |
Official Site Inspections
http://www.eloracpharma.com
- Host name: 172.67.140.228
- IP address: 172.67.140.228
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Elorac"
Elorac - Crunchbase Company Profile & Funding
Elorac is a specialty pharmaceutical frm in the development and commercialization of novel products for dermatology, allergy and oncology.See details»
Elorac, Inc - LinkedIn
Elorac, Inc | 498 followers on LinkedIn. Elorac, Inc. is a specialty pharmaceutical company devoted to developing, commercializing, and marketing dermatology products. Elorac has over 20 novel ...See details»
Elorac, Inc. Company Profile | Chicago, Illinois | Competitors ...
Printer Friendly View Address: 205 W Wacker Dr Chicago, IL, 60606-1216 United States See Other Location Phone: Website: www.eloracpharma.com Employees (this site): Modelled …See details»
Elorac Company Profile - Office Locations, Competitors, Revenue
Elorac has 5 employees at their 1 location. See insights on Elorac including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Elorac, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore Elorac, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 1 news, Disease Domain:Immune System Diseases, Technology ...See details»
Elorac (GBYHPR3SCV73)
Elorac (UEI GBYHPR3SCV73, CAGE 6MHC4) based in Vernon Hills IL federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Elorac: Employee Directory | ZoomInfo.com
Elorac, Inc. is a privately owned, specialty pharmaceutical company engaged in the development and commercialization of novel products for dermatology, allergy and oncology. The Company …See details»
Elorac Company Profile | Management and Employees List
Elorac Profile and History Elorac, Inc. is a privately owned, specialty pharmaceutical company engaged in the development and commercialization of novel products for dermatology, allergy …See details»
Home - Norac Pharma
ABOUT US SOCMA Award Received! Norac Pharma Awarded National Performance Improvement Honor: SOCMA Recognizes Norac Pharma for Commitment to Improving Environmental, Health, Safety &… Read More …See details»
Elorac, Inc. Company Information - Drugs.com
Drugs Associated with Elorac, Inc. Elorac, Inc. manufactures, markets and/or distributes more than 6 drugs in the United States. Medications listed here may also be marketed under …See details»
HOME - ORIC Pharmaceuticals
Our bold vision is to discover, develop and commercialize innovative therapies that address cancer resistance, including by making existing therapies work better and longer. Profound …See details»
Elorac, Inc Management Team | Org Chart - RocketReach
Top Elorac, Inc Management Employees Mary Bonau Pharmaceutical at Elorac, Inc Plano, TX, US View 2 singlecare.com eloracpharma.com 2 972989XXXX 972403XXXXSee details»
Elorac Org Chart + Executive Team - The Official Board
See the executive team of Elorac and its org chart, featuring 6 leaders like Jeffrey Bernstein and Scott PhillipsSee details»
Elorac, Inc Company Overview, Contact Details & Competitors
Elorac, Inc Pharmaceutical Manufacturing United States 11-50 Employees Elorac, Inc. is a specialty pharmaceutical company devoted to developing, commercializing, and marketing …See details»
Explore eloracpharma.com Company Profile | Tomba
Discover everything about eloracpharma.com, including contact information, services offered, and key competitors. information about the website eloracpharma.com.See details»
Elorac - Company Info, Employees & Competitors
View Elorac eloracpharma.com location in 100 fairway drive, vernon hills, illinois, 60061, united states, revenue, industry and description. Find related and similar companies as well as …See details»
Elorac Pharmaceuticals | VentureRadar
Sun BioPharma USA Privately Held Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and MGI …See details»
Elorac | Biopharma, Pharmaceutical
Elorac | Biopharma, Pharmaceutical | Founded 2009-01-01Elorac, Inc. is a privately owned, specialty pharmaceutical company engaged in the development and commercialization of …See details»
Christopher Gabanski - Chief Commercial Officer, Director - LinkedIn
Chief Commercial Officer, Director at Elorac, Inc. · Christopher Gabanski is Chief Commercial Officer, Director of Elorac, Inc. a specialty pharmaceutical company engaged in the …See details»
Elorac, Inc. | Insights
The first positive Phase III data from AbbVie Inc. and partner Neurocrine Biosciences Inc. for elagolix for the treatment of heavy menstrual bleeding in women with uterine fibroids puts pressuSee details»